162 related articles for article (PubMed ID: 35355515)
1. Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort Analysis.
Huang L; Wei G; Chen N; Liu J; Wang Z; Yu Y; Qiu M
Clin Med Insights Oncol; 2022; 16():11795549221085054. PubMed ID: 35355515
[TBL] [Abstract][Full Text] [Related]
2. Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
Lin Q; Ding K; Zhao R; Wang H; Wei Y; Ren L; Ye Q; Cui Y; He G; Tang W; Feng Q; Zhu D; Chang W; Wang X; Liang L; Zhou G; Liang F; Ye F; Wang J; Fan J; Xu J
Eur J Cancer; 2023 Sep; 191():112961. PubMed ID: 37473466
[TBL] [Abstract][Full Text] [Related]
3. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial.
Park EJ; Baek JH; Choi GS; Park WC; Yu CS; Kang SB; Min BS; Kim JH; Kim HR; Lee BH; Oh JH; Jeong SY; Jung M; Ahn JB; Baik SH
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824392
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
[TBL] [Abstract][Full Text] [Related]
5. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; Van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Hadj JO; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M;
Ann Oncol; 2024 Jun; ():. PubMed ID: 38852675
[TBL] [Abstract][Full Text] [Related]
6. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
[TBL] [Abstract][Full Text] [Related]
7. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
9. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
[TBL] [Abstract][Full Text] [Related]
11. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J;
J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408
[TBL] [Abstract][Full Text] [Related]
12. Modern-day palliative chemotherapy for metastatic colorectal cancer: does colonic resection affect survival?
Lau JWL; Chang HSY; Lee KY; Gwee YX; Lee WQ; Chong CS
ANZ J Surg; 2018 Nov; 88(11):E772-E777. PubMed ID: 29938886
[TBL] [Abstract][Full Text] [Related]
13. Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases.
Huang M; Yang Y; Li Q; Wang C; Liang L; Zhu X; Zhang W; Chen Z; Huang D; Li W; Zhang X; Zhao X; Qiu L; Geng Q; Yu N; Du W; Sun S; Sheng X; Li X; Guo W
Front Oncol; 2022; 12():747124. PubMed ID: 35174078
[TBL] [Abstract][Full Text] [Related]
14. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
[TBL] [Abstract][Full Text] [Related]
15. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
[TBL] [Abstract][Full Text] [Related]
16. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
de Mestier L; Neuzillet C; Pozet A; Desot E; Deguelte-Lardière S; Volet J; Karoui M; Kianmanesh R; Bonnetain F; Bouché O
Eur J Surg Oncol; 2014 Jun; 40(6):685-91. PubMed ID: 24630774
[TBL] [Abstract][Full Text] [Related]
17. The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis.
Liang Z; Liu Z; Huang C; Chen X; Zhang Z; Xiang M; Hu W; Wang J; Feng X; Yao X
Front Surg; 2022; 9():1047373. PubMed ID: 36684350
[TBL] [Abstract][Full Text] [Related]
18. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
Urvay S; Eren T; Civelek B; Kilickap S; Yetiysigit T; Ozaslan E
J BUON; 2020; 25(2):939-944. PubMed ID: 32521889
[TBL] [Abstract][Full Text] [Related]
19. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis.
Li S; Ji L; Huang J; Wang Y; Liu P; Zhang W; Lou Z
Int J Colorectal Dis; 2023 Aug; 38(1):214. PubMed ID: 37581775
[TBL] [Abstract][Full Text] [Related]
20. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
Ergun Y; Bal O; Dogan M; Ucar G; Dirikoc M; Acikgoz Y; Bacaksiz F; Uncu D
J Res Med Sci; 2020; 25():14. PubMed ID: 32174986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
